259 related articles for article (PubMed ID: 20412431)
1. Sex steroid receptors in male human bladder: expression and biological function.
Chavalmane AK; Comeglio P; Morelli A; Filippi S; Fibbi B; Vignozzi L; Sarchielli E; Marchetta M; Failli P; Sandner P; Saad F; Gacci M; Vannelli GB; Maggi M
J Sex Med; 2010 Aug; 7(8):2698-713. PubMed ID: 20412431
[TBL] [Abstract][Full Text] [Related]
2. Estrogens regulate humans and rabbit epididymal contractility through the RhoA/Rho-kinase pathway.
Fibbi B; Filippi S; Morelli A; Vignozzi L; Silvestrini E; Chavalmane A; De Vita G; Marini M; Gacci M; Manieri C; Vannelli GB; Maggi M
J Sex Med; 2009 Aug; 6(8):2173-86. PubMed ID: 19453906
[TBL] [Abstract][Full Text] [Related]
3. Mechanical stretch upregulates proteins involved in Ca2+ sensitization in urinary bladder smooth muscle hypertrophy.
Boopathi E; Gomes C; Zderic SA; Malkowicz B; Chakrabarti R; Patel DP; Wein AJ; Chacko S
Am J Physiol Cell Physiol; 2014 Sep; 307(6):C542-53. PubMed ID: 25031021
[TBL] [Abstract][Full Text] [Related]
4. Tadalafil effect on metabolic syndrome-associated bladder alterations: an experimental study in a rabbit model.
Vignozzi L; Filippi S; Comeglio P; Cellai I; Morelli A; Maneschi E; Sarchielli E; Gacci M; Carini M; Vannelli GB; Maggi M
J Sex Med; 2014 May; 11(5):1159-72. PubMed ID: 24612540
[TBL] [Abstract][Full Text] [Related]
5. Differential Effects of Testosterone and Estradiol on Clitoral Function: An Experimental Study in Rats.
Comeglio P; Cellai I; Filippi S; Corno C; Corcetto F; Morelli A; Maneschi E; Maseroli E; Mannucci E; Fambrini M; Maggi M; Vignozzi L
J Sex Med; 2016 Dec; 13(12):1858-1871. PubMed ID: 27914563
[TBL] [Abstract][Full Text] [Related]
6. BXL-628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladder.
Morelli A; Vignozzi L; Filippi S; Vannelli GB; Ambrosini S; Mancina R; Crescioli C; Donati S; Fibbi B; Colli E; Adorini L; Maggi M
Prostate; 2007 Feb; 67(3):234-47. PubMed ID: 17163492
[TBL] [Abstract][Full Text] [Related]
7. Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome.
Morelli A; Comeglio P; Filippi S; Sarchielli E; Cellai I; Vignozzi L; Yehiely-Cohen R; Maneschi E; Gacci M; Carini M; Adorini L; Vannelli GB; Maggi M
J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):80-92. PubMed ID: 22406511
[TBL] [Abstract][Full Text] [Related]
8. The regulatory effect of sex steroids on the RhoA/ROCK pathway in the rat distal vagina.
Cellai I; Comeglio P; Filippi S; Martinelli S; Villanelli F; Amore F; Rapizzi E; Maseroli E; Cipriani S; Raddi C; Guarnieri G; Sarchielli E; Danza G; Morelli A; Rastrelli G; Maggi M; Vignozzi L
J Sex Med; 2023 Jan; 20(1):1-13. PubMed ID: 36897236
[TBL] [Abstract][Full Text] [Related]
9. Vardenafil modulates bladder contractility through cGMP-mediated inhibition of RhoA/Rho kinase signaling pathway in spontaneously hypertensive rats.
Morelli A; Filippi S; Sandner P; Fibbi B; Chavalmane AK; Silvestrini E; Sarchielli E; Vignozzi L; Gacci M; Carini M; Vannelli GB; Maggi M
J Sex Med; 2009 Jun; 6(6):1594-1608. PubMed ID: 19473460
[TBL] [Abstract][Full Text] [Related]
10. RhoA/ROCK pathway mediates the effect of oestrogen on regulating epithelial-mesenchymal transition and proliferation in endometriosis.
Huang ZX; Mao XM; Wu RF; Huang SM; Ding XY; Chen QH; Chen QX
J Cell Mol Med; 2020 Sep; 24(18):10693-10704. PubMed ID: 32725958
[TBL] [Abstract][Full Text] [Related]
11. Obstruction alters muscarinic receptor-coupled RhoA/Rho-kinase pathway in the urinary bladder of the rat.
Takahashi N; Shiomi H; Kushida N; Liu F; Ishibashi K; Yanagida T; Shishido K; Aikawa K; Yamaguchi O
Neurourol Urodyn; 2009; 28(3):257-62. PubMed ID: 19229948
[TBL] [Abstract][Full Text] [Related]
12. RhoA/ROCK signaling regulates smooth muscle phenotypic modulation and vascular remodeling via the JNK pathway and vimentin cytoskeleton.
Tang L; Dai F; Liu Y; Yu X; Huang C; Wang Y; Yao W
Pharmacol Res; 2018 Jul; 133():201-212. PubMed ID: 29791873
[TBL] [Abstract][Full Text] [Related]
13. Effects of estrogen, raloxifene, and levormeloxifene on the expression of Rho-kinase signaling molecules in urethral smooth muscle cells.
Ning N; Lin G; Lue TF; Lin CS
Urology; 2010 Dec; 76(6):1517.e6-11. PubMed ID: 20970835
[TBL] [Abstract][Full Text] [Related]
14. Benign prostatic hyperplasia: a new metabolic disease?
Vignozzi L; Rastrelli G; Corona G; Gacci M; Forti G; Maggi M
J Endocrinol Invest; 2014 Apr; 37(4):313-22. PubMed ID: 24458832
[TBL] [Abstract][Full Text] [Related]
15. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
[TBL] [Abstract][Full Text] [Related]
16. Estradiol induces endothelial cell migration and proliferation through estrogen receptor-enhanced RhoA/ROCK pathway.
Oviedo PJ; Sobrino A; Laguna-Fernandez A; Novella S; Tarín JJ; García-Pérez MA; Sanchís J; Cano A; Hermenegildo C
Mol Cell Endocrinol; 2011 Mar; 335(2):96-103. PubMed ID: 20615453
[TBL] [Abstract][Full Text] [Related]
17. Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms--action of two new agents.
Kumar R; Verma V; Sarswat A; Maikhuri JP; Jain A; Jain RK; Sharma VL; Dalela D; Gupta G
Invest New Drugs; 2012 Apr; 30(2):582-93. PubMed ID: 21181231
[TBL] [Abstract][Full Text] [Related]
18. Bakuchiol suppresses oestrogen/testosterone-induced Benign Prostatic Hyperplasia development through up-regulation of epithelial estrogen receptor β and down-regulation of stromal aromatase.
Miao L; Jiao C; Shao R; Qi Y; Fan G; Li X; Wang Y; Zhu Y; Zhang J; Gao X
Toxicol Appl Pharmacol; 2019 Oct; 381():114637. PubMed ID: 31238046
[TBL] [Abstract][Full Text] [Related]
19. Testosterone regulates RhoA/Rho-kinase signaling in two distinct animal models of chemical diabetes.
Vignozzi L; Morelli A; Filippi S; Ambrosini S; Mancina R; Luconi M; Mungai S; Vannelli GB; Zhang XH; Forti G; Maggi M
J Sex Med; 2007 May; 4(3):620-632. PubMed ID: 17498101
[TBL] [Abstract][Full Text] [Related]
20. Opposite effects of tamoxifen on metabolic syndrome-induced bladder and prostate alterations: a role for GPR30/GPER?
Comeglio P; Morelli A; Cellai I; Vignozzi L; Sarchielli E; Filippi S; Maneschi E; Corcetto F; Corno C; Gacci M; Vannelli GB; Maggi M
Prostate; 2014 Jan; 74(1):10-28. PubMed ID: 24037776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
